At 4.9% CAGR, the Middle East & Africa Hemodynamic Monitoring System Market is projected to be worth US$ 74.79 million by 2028, says Business Market Insights

According to Business Market Insights’ research, the Middle East & Africa hemodynamic monitoring system market was valued at US$ 56.04 million in 2022 and is expected to reach US$ 74.79 million by 2028, registering a CAGR of 4.9% from 2022 to 2028. Rising cardiovascular disease prevalence and growing geriatric population are the critical factors attributed to the Middle East & Africa hemodynamic monitoring system market expansion.

Cardiovascular diseases (CVDs) cause millions of deaths every year worldwide. Hemodynamic monitors allow measurement of cardiac functions and blood circulation in cardiac patients. The monitoring allows physicians to measure blood pressure from inside the veins, arteries, and heart. Thus, growing prevalence of cardiovascular diseases is surging the demand for hemodynamic monitors and this is directly impacting the growth of the Middle East & Africa hemodynamic monitoring system market.

On the contrary, risks associated with invasive hemodynamic monitoring systems hampers the Middle East & Africa hemodynamic monitoring system market.

Based on type, Middle East & Africa hemodynamic monitoring system market is segmented into non-invasive hemodynamic monitoring systems, minimally invasive hemodynamic monitoring systems, and invasive hemodynamic monitoring systems. The invasive hemodynamic monitoring systems segment held 71.8% share of Middle East & Africa hemodynamic monitoring system market in 2022, amassing US$ 40.23 million. It is projected to garner US$ 52.82 million by 2028 to expand at 4.6% CAGR during 2022–2028.

Based on product, the Middle East & Africa hemodynamic monitoring system market is segmented into monitors and disposables. The disposables held 71.4% share of Middle East & Africa hemodynamic monitoring system market in 2022, amassing US$ 40.03 million. It is projected to garner US$ 52.43 million by 2028 to expand at 4.6% CAGR during 2022–2028.

Based on end user, the Middle East & Africa hemodynamic monitoring system market is segmented into hospitals, home care, cath labs, and ambulatory care center. The hospitals segment held 83.6% share of Middle East & Africa hemodynamic monitoring system market in 2022, amassing US$ 46.82 million. It is projected to garner US$ 63.25 million by 2028 to expand at 5.1% CAGR during 2022–2028.

Based on country, the Middle East & Africa hemodynamic monitoring system market has been categorized into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that South Africa captured 33.9% share of Middle East & Africa hemodynamic monitoring system market in 2022. It was assessed at US$ 18.99 million in 2022 and is likely to hit US$ 26.36 million by 2028, exhibiting a CAGR of 5.6% during the forecast period.

Key players dominating the Middle East & Africa hemodynamic monitoring system market are Baxter International Inc; DELTEX MEDICAL; Edwards Lifesciences Corporation; General Electric Co; Getinge Group; ICU MEDICAL INC.; International Business Machines Corp; Koninklijke Philips NV; Masimo; and Siemens Healthineers AG, among others.

• In April 2019; Edwards Lifesciences Completed the Acquisition of CASMED. CAS Medical Systems, Inc., a medical technology company dedicated to non-invasive brain and tissue oxygenation monitoring. Edwards has acquired CASMED's FORE-SIGHT non-invasive cerebral oxygenation technology. Edwards plans to pair the FORE-SIGHT technology with the company's HemoSphere advanced hemodynamic monitoring platform, which would create a unique offering of enhanced recovery tools and predictive analytics capabilities for clinicians. The acquisition of the FORE-SIGHT technology represents an opportunity to grow the Edwards critical care portfolio and further strengthen the company's leadership in smart monitoring technologies. 

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com